G protein

(redirected from G-protein)
Also found in: Dictionary, Medical, Wikipedia.
Related to G-protein: Adenylyl cyclase

G protein

[′jē ‚prō‚tēn]
(cell and molecular biology)
References in periodicals archive ?
G-protein [beta]3 subunit C825T polymorphism, sodium and arterial blood pressure: a community-based study of Japanese men and women.
Global G-Protein Coupled Receptors (GPCRs) Industry
the leader in discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced the successful completion of a Phase I first-in-human clinical trial of TRV130.
Rockville, MD) has patented PSGR, a novel prostate specific gene with homology to a G-protein coupled receptor overexpressed in prostate cancer.
The 2012 Nobel Prize for Chemistry has been awarded to Robert Lefkowitz and Brian Kobilka for their work on the G-protein coupled receptor system and its application in medical science
Biotechnology Industry: Global G-Protein Coupled Receptors (GPCRs) industry
These channels are activated in response to stimulation of the G-protein coupled receptors that, leads to the hydrolysis of [PIP.
Uniondale, NY; 516-222-0023), on a non-exclusive basis, its yeast G-protein coupled receptors technologies, including various reagents, a library of over 30,000 yeast strains and proprietary bio-informatics software.
the leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced that it is presenting a poster featuring Phase 1 clinical data on TRV027 at the 16th Annual Heart Failure Society of America Meeting being held in Seattle, WA, September 9th-12th.
Table 2: World Recent Past, Current & Future Market Analysis for G-Protein Coupled Receptors (GPCRs) Addressing Drugs With Annual Sales Figures in US$ Billion for Years 2007 through 2015 (includes corresponding Graph/Chart) II-36
The agreement allows OSI to access the Cyanamid technology covered in four issued United States patents which include claims for recombinant expression of a variety of targets in yeast, including G-protein coupled receptors, hybrid G-protein coupled receptors and orphan receptors for use in human therapeutics.
the leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, announced that results have been published from a new preclinical pharmacology study of its phase 2 clinical acute heart failure molecule, TRV027.